Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Mirae Asset Venture Investments (India)
investor
India
- Mumbai, Maharashtra
- 02/12/2022
- Series D
- $80,000,000
Mirae Asset manages $1.5 B across its four funds - Mirae Asset Naver Asia Growth ($1 B), Mirae Asset Naver I, Mirae Asset GS Retail, Mirae Asset Celltrion and other MAVI funds for venture investment with presence in South Korea, India and China.
Our India portfolio includes - Ola Cabs, BigBasket, Zomato, Shadowfax, Zolo Stays, Kreditbee, Raise Financial Services, Koo App, Jai Kisan, Trell, Unacademy, Sharechat, Jupiter.
Our Global portfolio includes - Didi Chuxing (China), Grab (SE Asia), HappyFresh (Indonesia), Bukalapak (Indonesia), Glovo (Europe), RedDoorz (SE Asia), Deskera (SE Asia), Impossible Foods (US), Market Kurly (South Korea)
- Industry Investment Management
- Website https://miraeassetvc.co.in/
- LinkedIn https://www.linkedin.com/company/miraeassetventure/
Related People
Ashish DaveFounder
India -
Mumbai, Maharashtra
Building Mirae Asset's Venture practice in India
LinkedIn
https://www.linkedin.com/in/daveash/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)